Gary Quartello, DPM
Foot Surgery · Berkeley Hts, NJNPI 1902804479
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Musculoskeletal Transplant Foundation Inc. at 50.8% of the total. Reporting peaked in 2020 at $1,693 and has fallen 60.5% since, to $668 in 2025. Among foot surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 114 payments — averaging $39.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$2K
- Smith+Nephew$469
- Organogenesis Inc.$325
- Kerecis Limited$273
- Urgo Medical North America, LLC$159
- Lifenet Health$155
- plus $815 from 16 others
What the payments were for
- Travel & lodging$391%
- Food & beverage$4,42399%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 34 | $2,267 |
| Smith+Nephew | 36 | $469 |
| Organogenesis Inc. | 7 | $325 |
| Kerecis Limited | 6 | $273 |
| Urgo Medical North America, LLC | 2 | $159 |
| Lifenet Health | 2 | $155 |
| Integra Lifesciences Corporation | 1 | $129 |
| Reapplix Inc. | 4 | $102 |
| Polarityte, Inc. | 2 | $85 |
| Solventum Corporation | 2 | $79 |
| KCI USA, Inc. | 3 | $74 |
| AbbVie | 3 | $62 |
| Paratek Pharmaceuticals, Inc. | 3 | $50 |
| Tactile Systems Technology Inc | 1 | $33 |
| Acera Surgical, Inc. | 1 | $32 |
| Bioventus LLC | 1 | $31 |
| Paragon 28, Inc. | 1 | $31 |
| Sanara Medtech Inc. | 1 | $26 |
| Treace Medical Concepts, Inc. | 1 | $23 |
| Convatec Inc. | 1 | $23 |
| Stryker | 1 | $22 |
| Medline Industries LP | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,462 in reported general payments places this provider in the 90th percentile of 59 foot surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 25 | $8,058 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $256 |
| Doxycycline Hyclate | 30 | $218 |
| Cefadroxil | 24 | $198 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $161 |
| Terbinafine Hcl | 18 | $146 |
| Mupirocin | 15 | $96 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $469 | $8,05825 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 59 foot surgery providers in New Jersey.
Other foot surgery in Berkeley Hts
- Steven GoldsteinLivingston$208K
- Paul SullivanMarlton$7K
- Timothy SorensenCape May Court House$5K
- Greg RubinsteinTeaneck$5K
- Christopher MullinAberdeen$5K
- Graciani MartinezDover$4K
- James CancilleriNorthfield$4K
- Frank KillianToms River$3K
- Bowen YangHoboken$3K
- Craig BachmanOld Bridge$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.